Pharmaceuticals — Editors

Journal Contact

Pharmaceuticals Editorial Office
MDPI AG, St. Alban-Anlage 66, 4052 Basel, Switzerland
Tel. +41 61 683 77 34; Fax: +41 61 302 89 18
Ms. Changzhen Fu

Assistant Managing Editor
MDPI Wuhan Office, No.6 Jingan Road, 5.5 Creative Industry Park, Floor 25th. 430064 Wuhan, Hubei Province, China
Tel. +86-27-87808658; Fax: +86-27-87612588


Dr. Jean Jacques Vanden Eynde

Formerly head of the Department of Organic Chemistry (FS), University of Mons-UMONS, 7000 Mons, Belgium
Interests: heterocycles; microwave-induced synthesis; medicinal chemistry; green chemistry
Prof. Dr. Shin Mineishi

Associate Editor
Director, Bone Marrow Transplantation and Cell Therapy Program, Division of Hematology & Oncology, The University of Alabama at Birmingham, 1802 6th Avenue South, NP 2562, Birmingham, AL 35294-3300, USA
Interests: bone marrow transplantation; graft versus host disease; complications after stem cell transplantation; reduced intensity stem cell transplantation; HLA-mismatch stem cell transplantation; graft engineering; cell therapy; and gene therapy
Dr. Annie Mayence

Associate Editor
Formerly professor at the Haute Ecole Provinciale de Hainaut-Condorcet, 7330 Saint-Ghislain, Belgium
Dr. Derek J. McPhee *

Former Editor-in-Chief
Senior Director, Technology Strategy, Amyris, Inc., 5885 Hollis St, Suite 100, Emeryville, CA 94608, USA
Interests: organic synthesis; medicinal chemistry; biotechnology
* Founding Editor-in-Chief and Editor-in-Chief up to 29 January 2015.

Editorial Board

Prof. Jean-Pierre Bazureau

University of Rennes 1, Institute of Chemical Sciences Rennes ICSR UMR CNRS 6226, Building 10A, Room 207, Campus de Beaulieu, 263 Avenue du General Leclerc, CS 74205, 35042 RENNES Cedex, France
Interests: synthetic organic chemistry under microwave; medicinal chemistry; design and heterocyclic chemistry for cancer and CNS diseases
Prof. Dr. Joachim Jose

PharmaCampus Institute of Pharmaceutical and Medicinal Chemistry, Westfälische Wilhelms-Universität, Corrensstr. 48, 48149, Muenster, Germany
Interests: autodisplay; assay development and inhibitor testing; whole cell biocatalysts for synthesis of drugs and building blocks; directed evolution of enzyme inhibitors and biocatalysts; biosensor development and diagnostic tools
Contribution: Special Issue: An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2
Prof. Dr. Christopher W.K. Lam

State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, China
Interests: allergy and clinical immunology; nephrology; diabetology; toxicology; clinical biochemistry; laboratory medicine; Chinese medicine
Contribution: In other journals:
Special Issue: Phytochemicals: Analytical and Medicinal Chemistry
Special Issue: Herbal Medicine Research
Dr. Viktor P. Lozitsky

Research Center "Biomedical Testing of Preparations and Products", Odessa, Ukraine
Interests: proteolysis inhibitors; virus-cell interactions; antiviral compounds
Dr. Louis M. Mansky

Institute for Molecular Virology, University of Minnesota, 18-242 Moos Tower, 515 Delaware St. SE, Minneapolis, MN 55455, USA
Interests: antiretroviral; nucleoside; mutation; drug synergy; therapeutic indices
Contribution: Special Issue: Drug Repositioning
In other journals:
Special Issue: Recent Advances in HTLV Research 2015
Dr. Suzanne Peyrottes

Institute for Biomolecules Max Mousseron (IBMM), UMR5247‐CNRS–UM–ENSCM, University Montpellier, cc1704, Place E. Bataillon, 34095 Montpellier, France
Interests: targeting of phosphorylated effectors; synergetic effect in antiviral chemotherapy; synthesis and study of phosphonate analogues as potential therapeutic agents; development of choline analogues as anti‐malarial agents
Dr. Maria Emília de Sousa

Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências, Químicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira 228, 4050-313, Porto, Portugal; Centro Interdisciplinar de Investigação Marinha e Ambiental (CIIMAR/CIMAR), Universidade do Porto, Rua dos Bragas 289, 4050-123 Porto, Portugal
Interests: medicinal chemistry; organic synthesis; heterocycles, P-glycoprotein; anticancer; anticoagulants; chiral drugs
Contribution: Special Issue: Grand Celebration: 100th Anniversary of the Discovery of Heparin
Special Issue: Selected papers from the 11th National Meeting of Organic Chemistry and 4th Meeting of Therapeutic Chemistry in Portugal
In other journals:
Special Issue: Selected Papers from the 6th International Conference on Natural Products for Health and Beauty (NATPRO 6)
Special Issue: Can Membrane Transporters Contribute to Drug Discovery?
Prof. Dr. Klaus Kopka

Division of Radiopharmaceutical Chemistry, Research Program Imaging and Radiooncology, German Cancer Research Center (dkfz), Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany
Interests: radiopharmaceutical sciences; labeling chemistry; medicinal chemistry; PET tracers; radiopharmaceuticals for diagnostics and endoradiotherapy; small molecules; peptides; antibodies and derivatives thereof
Contribution: Special Issue: Radiopharmaceutical Chemistry between Imaging and Radioendotherapy
Special Issue: Emerging Theranostic Tracers in the Context of Radiopharmaceutical Drug Development
Prof. Dr. Peter A. Leggat

College of Public Health, Medical and Veterinary Sciences, Division of Tropical Health and Medicine, James Cook University, Townsville Qld 4811, Australia
Interests: occupational health and safety; injury prevention; pharmaceuticals; aerospace medicine; geographic and travel medicine
Contribution: Special Issue: Tropical Medicine
In other journals:
Special Issue: Occupational Health Issues in the New Millennium
Prof. Dr. Jane McHowat

Department of Pathology, Saint Louis University School of Medicine, Schwitalla Hall, Room M207, 1402 S. Grand Blvd, St. Louis, MO 63104, USA
Interests: inflammation; phospholipases; breast cancer; interstitial cystitis; bladder; atherosclerosis; platelet-activating factor
Contribution: Topical Collection: Non-Steroidal Anti-Inflammatory Drugs
Prof. Dr. Leonidas A. Phylactou

Acting Chief Executive Medical Director, The Cyprus Institute of Neurology & Genetics, PO Box 23462, 1683 Nicosia, Cyprus
Interests: RNA biology; regulatory RNA molecules; muscle regeneration, identification of genetic defects in inherited diseases
Contribution: Special Issue: Gene Therapy
Special Issue: Towards Understanding the Mechanisms and Curing Of Muscular Dystrophy Diseases
Special Issue: Chemically Modified Antisense Oligonucleotides: Promising Tools for the Therapy of Diseases
In other journals:
Special Issue: Towards Understanding the Mechanisms and Curing Of Muscular Dystrophy Diseases
Prof. Dr. Vladimir P. Torchilin

University Distinguished Professor, Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, 140 The Fenway, room 214, 360 Huntington Avenue Boston, MA 02115, USA
Interests: drug carriers; drug delivery sytems; drug targeting; liposomes; micelles; experimental cancer immunology; imaging agents
Contribution: Special Issue: Cell-penetrating Peptides 2012
In other journals:
Special Issue: Biodegradability of Materials
Special Issue: Biodegradability of Materials
Special Issue: Micellar Drug Delivery
Dr. Guangshun Wang

Department of Pathology & Microbiology University of Nebraska Medical Center, USA
Interests: Host defense antimicrobial peptides, Structural bioinformatics, Biomolecular NMR
Contribution: Special Issue: Identification and Characterization of Antimicrobial Peptides with Therapeutic Potential
Special Issue: Antimicrobial Peptides: Expanded Activity Spectrum and Applications
Prof. Dr. Paul Cos

Laboratory of Microbiology, Parasitology and Hygiene (LMPH), Department of Pharmaceutical Sciences, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences Antwerp University, campus drie eiken, building S, office 7.26 Universiteitsplein 1, B-2610 Antwerp, Belgium
Interests: anti-infective agents; biofilm; bacterial virulence; oxidative stress; antibacterial; antifungal; antiparasitic and antiviral
Contribution: Special Issue: Anti-Infective Agents
In other journals:
Special Issue: Anti-Infective Agents
Prof. Dr. Thomas Efferth

Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, University of Mainz, Staudinger Weg, 555128 Mainz, Germany
Interests: cancer; pharmacogenomics; molecular docking and virtual drug screening; molecular pharmacology; natural products; phytotherapy
Contribution: Special Issue: Phytomedicine
In other journals:
Special Issue: Herbal Medicine Research
Dr. Arthur Gomtsyan

Abbvie Inc, Drug Discovery, 1 North Waukegan Road, Department ZR09, Bldg. AP10, North Chicago, IL 60064, USA
Interests: medicinal chemistry; synthetic organic chemistry; drug design in the area of pain and dermatology research
Contribution: Special Issue: Advances in Drug Design
Prof. Dr. Michael Gütschow

Pharmaceutical Institute, University of Bonn, An der Immenburg 4, 53115 Bonn, Germany
Interests: synthetic organic chemistry; enzyme kinetics; mechanism-based enzyme inhibitors; inhibitors of proteases
Dr. Kenneth A. Jacobson

Laboratory of Bioorganic Chemistry and Molecular Recognition Section, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bldg. 8A, Rm. B1A-19, 8 Center Dr., MSC-0810 Bethesda, MD 20892-0810, USA
Interests: medicinal chemistry; G protein-coupled receptors; receptor pharmacology; cell signaling; molecular modeling; purinergic receptors; adenosine receptors; chemistry of nucleosides and nucleotides; radiochemistry; nanotechnology and nanoscience
Dr. Svend Borup Jensen

Nuklearmedicinsk Afdeling - Hobrovej 18-22, Postboks 365, 9100 Aalborg, Denmark
Interests: PET-radiochemistry, gallium-68, drug degradation profiles; medicinal gum; infection imaging, analytical methods; medicinal chemistry
Contribution: Special Issue: Radiochemistry
Special Issue: Preparation of Radiopharmaceuticals and Their Use in Drug Development
In other journals:
Special Issue: Radiochemistry
Special Issue: Preparation of Radiopharmaceuticals and Their Use in Drug Development
Prof. Dr. Philip S. Low

Director of the Purdue Center for Drug Discovery, Ralph C. Corley Distinguished Professor, Department of Chemistry 720 Clinic Drive, Purdue University, West Lafayette, IN 47907, USA
Website: http:/
Interests: targeted Therapeutics; fluorescence-guided surgery; techniques for pathogen detection; human red blood cell membrane
Dr. Mark Murphy

Research Immunology, Actelion Pharmaceuticals Ltd, Gewerbestrasse 16, CH- 4123 Allschwil, Switzerland
Interests: immunology; targeted therapies for inflammatory and autoimmune diseases; signal transduction pathways as innovative therapeutic targets; stem cells; protein-protein interactions; targeted therapies for cancer; cytokines/chemokines
Contribution: Special Issue: Chemokines
Prof. Dr. Ricardo E. Pérez-Tomás

Department of Pathology and Experimental Therapy, Faculty of Medicine, University of Barcelona, Campus de Bellvitge., Lab.5101 C./ Feixa Llarga s/n E- 08907, Hospitalet de Llobregat, Barcelona, Spain
Interests: new molecules for cancer chemotherapy; apoptosis; signal transduction for cancer chemotherapy
Prof. Dr. Thomas Rades

Reseach Chair in Pharmaceutical Design and Drug Delivery Faculty of Health and Medical Sciences, Department of Pharmacy, University of Copenhagen, Universitetsparken 2, 2100 København Ø, Denmark
Interests: the solid state of drugs and dosage forms; poorly water soluble drugs; amorphous drugs and drug delivery systems; lipid based drug delivery systems; analytical techniques in the solid state
Prof. Dr. Maurizio Recanatini

Department of Pharmacy and Biotechnology, University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy
Interests: computational medicinal chemistry; structure-based ligand design & discovery; modeling and simulation of targets and ligand-target complexes of therapeutic interest; chemical biology
Contribution: Special Issue: Targeted Therapy
Prof. Dr. Osvaldo A. Santos-Filho

Universidade Federal do Rio de Janeiro, IPPN, CCS, Bloco H - Ilha do Fundão, Rio de Janeiro, RJ - 21941-902, Brazil
Interests: molecular modeling; computer-aided drug design; bioinformatics; chemoinformatics
Contribution: Special Issue: Chemoinformatics and Drug Design
Prof. Dr. Marc Le Borgne

Université de Lyon, Université Lyon 1, Faculté de Pharmacie - ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453 - INSERM US7, 69373 Lyon cedex 8, France
Interests: ligand-based drug design; small molecules; heterocycles; glycoconjugates; structure-activity relationships; structural optimization; stability studies; cancer; chemoresistances; infectious diseases
Prof. Dr. Oliver Reiser

Institut für Organische Chemie, Universität Regensburg, Universitätsstr. 31, 93053 Regensburg, Germany
Interests: asymmetric catalysis; stereoselective synthesis; natural product; synthesis; unnatural amino acids; foldamers
Contribution: Special Issue: Asymmetric Synthesis and Medicinal Chemistry
Prof. Dr. Domenico Ribatti

Dipartimento di Scienze Mediche di Base, Neuroscienze e Organi di Senso, Sezione di Anatomia Umana e Istologia, Piazza Giulio Cesare, 11 Policlinico, 70124 Bari, Italy
Interests: role of FGF-2 and VEGF in the vascularization of the chick embryo chorioallantoic membrane; angiogenesis
Contribution: Special Issue: Angiogenesis Inhibitors
Dr. Howard A. Young

Principal Investigator & Deputy Lab Chief, Laboratory of Experimental Immunology, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute at Frederick, Bldg. 560/31-23, Chandler Street, Frederick, MD 21702-1201, USA
Interests: interferon-gamma; cytokines, interferons, post transcriptional mRNA regulation; interleukins
Contribution: Special Issue: Interferons
Special Issue: Interferons 2015
In other journals:
Special Issue: Cytokines in Cancer
Prof. Dr. Tien L. Huang

Division of Basic and Pharmaceutical sciences, College of Pharmacy, Xavier University of Louisiana, 1 Drexel Drive, New Orleans, LA 70125, USA
Interests: medicinal chemistry; organic chemistry; anti-opportunistic agents; anti-parasitic agents; prodrugs
Prof. Dr. Gary J. Stephens

School of Pharmacy, University of Reading, Whiteknights, PO Box 228, Reading RG6 6AJ, UK
Interests: electrophysiology; voltage-gated calcium channels; cannabinoids; ion channels; GPCRs; pain; ataxia
Contribution: Special Issue: Calcium Antagonists
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert